Skip to main content
. Author manuscript; available in PMC: 2014 Jul 15.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2013 May 9;86(4):10.1016/j.ijrobp.2013.03.020. doi: 10.1016/j.ijrobp.2013.03.020

Table 1.

Patient and treatment-related characteristics (n = 503)

Characteristic Median Range
Age (y) 68 43–84
Prostate volume (cm3) 37 15–139
Serum prostate-specific antigen (ng/mL) 15.6 0.4–135
 <10 54%
 10–20 31%
 >20 15%
Gleason score 6 3–10
 2–6 62%
 7 27%
 8–10 11%
T stage
 T1 36%
 T2 47%
 T3 9%
 T4 1%
Prescribed radiation therapy dose (Gy) 72 64–78
Bladder solid volume (cm3) 148 37.2–841
Bladder solid mean dose (Gy) 50.4 10.5–70
Bladder wall volume (cm3) 51 18.6–208.7
Bladder wall mean dose (Gy) 50.2 9.7–68.8